Investigation of the tumourigenicity of Wi-38 and Hep-2 cells in ALS-treated white mice.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D005260:Female; D005856:Germ-Free Life; D006084:Graft Rejection; D007822:Laryngeal Neoplasms; D008168:Lung / Q000196:embryology; D051379:Mice; D009374:Neoplasms, Experimental / Q000473:pathology; D013997:Time Factors
D000961:Antilymphocyte Serum